Detalles de la búsqueda
1.
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
J Am Acad Dermatol;
2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653344
2.
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Br J Dermatol;
189(3): 327-335, 2023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37177895
3.
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.
JAMA Dermatol;
158(9): 1048-1056, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947364
4.
Dissatisfaction after implantation of multifocal intraocular lenses.
J Cataract Refract Surg;
37(5): 859-65, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21397457
Resultados
1 -
4
de 4
1
Próxima >
>>